Dianthus Therapeutics (DNTH) Cash from Operations Growth (1y) (2018 - 2025)
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Cash from Operations Growth (1y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.87% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -28.96% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 42.76% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 75.58% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 151.70% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 100.14% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 56.79% |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -43.67% |
| Jun 30, 2025 | -64.45% |
| Mar 31, 2025 | -84.93% |
| Dec 31, 2024 | -131.52% |
| Sep 30, 2024 | -112.84% |
| Jun 30, 2024 | -207.08% |
| Mar 31, 2024 | -45.28% |
| Dec 31, 2023 | -33.93% |
| Sep 30, 2023 | -161.02% |
| Jun 30, 2023 | 71.93% |
| Mar 31, 2023 | 47.91% |
| Dec 31, 2022 | 43.59% |
| Sep 30, 2022 | 216.41% |
| Jun 30, 2022 | -29.64% |
| Mar 31, 2022 | -17.69% |
| Dec 31, 2021 | -14.25% |
| Sep 30, 2021 | 2.50% |
| Jun 30, 2021 | 32.31% |
| Mar 31, 2021 | -0.70% |
| Dec 31, 2020 | 12.12% |